Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Inhibition of GSK3α/β impairs the progression of HNSCC
Lisa Schulz,
Ralph Pries
, Aruna Sree Lanka, Maren Drenckhan,
Dirk Rades
, Barbara Wollenberg
*
*
Corresponding author for this work
Clinic of Otorhinolaryngology
Clinic of Radiotherapy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of GSK3α/β impairs the progression of HNSCC'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Cell
100%
Neck
100%
Glycogen Synthase Kinase 3
100%
Squamous Cell
100%
Mesenchymal-Epithelial Transition
44%
Cancer Cell Line
33%
Neoplasm
22%
Cancer Growth
22%
Inflammatory Cytokine
22%
Glycogen Synthase Kinase 3 Inhibitor
22%
Immunohistochemistry
11%
Toll Like Receptor 3
11%
Experimental Therapy
11%
Tumor Necrosis Factor
11%
Base
11%
Western Blot
11%
Cytokine
11%
Cell Migration
11%
Toll Like Receptor 4
11%
Tumor Suppressor Protein
11%
Immunology and Microbiology
Squamous Cell
100%
Neck
100%
Epithelial Mesenchymal Transition
50%
Inflammatory Cytokine
25%
Cancer Cell Line
25%
TLR3
12%
Western Blot
12%
Tumor Necrosis Factor
12%
Growth Inhibition
12%
TLR4
12%
Promoter Region
12%
Cell Migration
12%
Cytokine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Glycogen Synthase Kinase 3
100%
Cytokine
33%
Neoplasm
22%
Cancer Growth
22%
Cell Viability
11%
Tumor Suppressor Protein
11%
Toll Like Receptor 4
11%
Tumor Promoter
11%
Western Blot
11%
Tumor Necrosis Factor
11%
Base
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Mesenchymal-Epithelial Transition
36%
Inflammatory Cytokine
18%
Wound Healing Assay
9%
Cell Migration
9%
Cytokine
9%
Tumor Suppressor Protein
9%
Western Blot
9%
TLR4
9%
Regulatory Network
9%
Promoter Region
9%